Atlanta to Serve as Stage for Premier Discussion on HIV Vaccine Development
NEW YORK, Sept. 14 /PRNewswire-USNewswire/ -- The Global HIV Vaccine Enterprise (the Enterprise) today announced that the Center for AIDS Research at Emory University (CFAR) in Atlanta, Georgia will serve as Local Host of AIDS Vaccine 2010, the largest and most important global scientific conference focused on AIDS vaccine research. AIDS 2010 is to be held September 28 to October 1, 2010. This annual international conference brings together scientists, community advocates, funders, and policy makers from around the world to hear cutting edge scientific results, exchange new ideas, educate future leaders, and engage a diverse community of scientists in the quest for an HIV vaccine.
"The Global HIV Vaccine Enterprise is committed to accelerating the search for a safe and effective vaccine through scientific collaboration and global initiatives that bring together the world's best researchers, scientific organizations, advocates, funders, and policy makers for common purpose," said Alan Bernstein, Ph.D., executive director, Global HIV Vaccine Enterprise. "Our annual AIDS Vaccine conference is one such initiative and we look forward to collaborating with the Center for AIDS Research at Emory University to plan and implement the premier conference dedicated to HIV vaccine research."
AIDS Vaccine 2010 will feature daily plenary presentations by leading researchers, clinicians, and community advocates, and oral and poster presentations of hundreds of research papers addressing every aspect of HIV vaccine development and testing. The conference is expected to attract more than 1,000 researchers, clinicians, and community advocates from around the world to Atlanta.
Eric Hunter, Ph.D., Georgia Research Alliance eminent scholar and co-director, C
'/>"/>
| SOURCE Global HIV Vaccine Enterprise Copyright©2009 PR Newswire. All rights reserved |